GENTING BHD
KLSE (MYR): GENTING (3182)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
4.66
Today's Change
+0.07 (1.53%)
Day's Change
4.59 - 4.70
Trading Volume
5,014,700
Prices
Discussions
34 people like this. Showing 50 of 73,970 comments
Yes @ElGato, ATK small fish follow the whales. TaiKor super nice guy n very helpful person. Besides those funds he is managing, he n family owns abt 1% of Taurx. But he always overly bullish, everytime after talking to him you wont want to sell your taurx shares. Ha!
TaiKor will try to arrange the best deal for Taurx to benchmark the highest price. Those deals rejected by Taurx will then flow to secondary market. But i think this China fund can easily absorb both Taurx's new issues + plenty of shares on secondary market.
2 days ago
Posted by MoneyMakers > 3 hours ago | Report Abuse
No use TauRx - alrdy fail experiment/placebo
Even latest fundraising undersubscribed - nobody want
------------------------
Aiyo got people really so stoopid ah? You smarter than billionaire investors?
Taurx rights issue was fully subscribed. GenB (LKT) even applied for excess rights else all the excess rights will be gobbled up by Chinese billionaire underwriter.
2 days ago
Posted by Mikecyc > 10 hours ago | Report Abuse
Haha Tin Kosong MonieM give lectures here ke …no more Shouting Rocket Limit Up ke as in Tsh .. don’t own deleted own posts loh …hahaha
--------------------------
@MM your enemy ah? Aiyo enemies chasing after you until coming into GenB forum. You must be spewing a lot of rubbish everywhere in i3. Tsk Tsk Tsk....
2 days ago
Posted by AngTayKor > 2022-11-07 15:54 | Report Abuse
TauRx Warrants Exercise
The latest results:-
1) 99.34% subscribed
2) amount raised = USD119.281 million.
------------------------------
Posted by MoneyMakers > 6 hours ago | Report Abuse
No use TauRx - alrdy fail experiment/placebo
Even latest fundraising undersubscribed - nobody want
------------------------------
Posted by MoneyMakers > 28 minutes ago | Report Abuse
Fact: TauRx reported only 99% warrant exercised (undersubscribed)
AngTK pls tell LKT or whichever chinese billionaire - still got 1% shares havent ‘gobble up’ kikiki
------------------------------
Aiyo really got people so dumb? Those attached piggyback warrants are non-transferable hence cannot be gobbled up by the underwriter. Its 99.34% VS 0.66%. Got 99.34% of warrant holders want. How can you say nobody want? Those 0.66% that failed to pay up on due date, its even better for other existing shareholders because less dilution at cheap price. ATK and many others also salivating want to gobble up those 0.66% warrant shares @USD45 each but legally unable to execute it. We are now talking abt issuing new shares at USD300/share. Those 0.66% that didnt pay up on due date too bad for them missed the golden huat opportunity to profit a few folds within a few months.
1 day ago
https://bm.cnfic.com.cn/sharing/share/articleDetail/165072276/1
@Michael your Chinese very good this article for you from the main news agency in China XinHua. Taurx got chance to get C.A in China also.
1 day ago
Yes. All the best to Taurx and GenB shareholders. We will clear all the hurdles! MCI patient group average score 20% reversal (improvement) from initial baseline on a phase 3 trial is God's gift to mankind to defeat this devastating AD.
1 day ago
Great to see more TauRx's news. Anxiously waiting for the re-rating of Genting TP. @ATK, thanks for sharing good news...
Let's all huat together. Cheers!
1 day ago
Haha no worries, a few years back , one of Genting Marketing Manager said the Income during the CNY 15 Days can cover 1 Year expenditures, foreseen Shl be improving …
1 day ago
Those who cut loss from Genting, please seek compensation from AngTayKor, Bob etc… hahaha…. I m right again! Cheers!
1 day ago
Posted by James_Bond > 4 minutes ago | Report Abuse
Those who cut loss from Genting, please seek compensation from AngTayKor, Bob etc… hahaha…. I m right again! Cheers!
------------------------
Loser Justborn dont anyhow put words into ATK's mouth. ATK did not say nasty things abt GenB or tell people here to cutloss. Go n check back the records posted here. Justborn you have no credibility here n serious character problem. Justborn is a shameless Liar, Fraud, Loser.
1 day ago
Aiyoyo AngTK obviously ‘nobody want’ = joke..main point is undersubscribe
This what happens when no life/friends - cannot understand joke
P/s: warrant usd45 ‘undersubscribe’ alrdy proof TauRx not worth usd300/share
1 day ago
TauRx alrdy fail experiment/placebo - yet still try get approval
Approval fail = more fundraising (if can find @ alrdy multiple experiment fail) or abandon proj
Want invest GenT better dont look TauRx - focus postpandemic travel better
1 day ago
If everyone here is truly a genuine Gent shareholder, u shud b happy for one another whether it’s TauRx or any other relevant news/information. Why behaving like dog bite dog bone kinda low and childish mentality? Promoting TauRx here benefits Gent shareholders as well. Tis platform shud b a harmonious place for all interested parties to share relevant and useful information for benefit of Gent shareholders primarily. Haiya… lose money quarrel, make money oso quarrel. Family with no peace and harmony disrupts good chi and feng sui energy.
1 day ago
Yeah, TQVM @ATK for yr kindness to share TauRx’s latest developments w us. I appreciate you.
1 day ago
Not good overhype TauRx leh
Better give accurate TauRx info (even if bad news)
1 day ago
Posted by James_Bond > 1 hour ago | Report Abuse
Clearly see AngTayKor is not gentleman! Haha…
------------------------------
Aiya obviously Justborn not happy with ATK hence keep cursing and falsely accusing ATK for all sorts of bad things. ATK was the first here to point out his 90m rupiah Casino Royale Fund is a fraud to fool the naive. From 5.00 kept on buying and supporting but price crashed below 4.50. 2 weeks ago after Justborn declared he had enough GenB shares and will will stop buying, price started to rally. Real 90m fund or fraud? You decide for yourself la.
1 day ago
Posted by MoneyMakers > 1 hour ago | Report Abuse
Not good overhype TauRx leh
Better give accurate TauRx info (even if bad news)
----------------------------
The bad news is, some funds only offered a low ball offer price to buy Taurx shares, which makes ATK's Taurx shares worth only USD30m.
The good news is, if big China Fund comes in and buy Taurx shares, ATK's Taurx shares will be worth USD58.5M (5% sold liow).
I dont have over rm90m cash la. There is only one liar, fraud and loser here that declared he has over rm90m cash. Hahaha.
1 day ago
ATK, the China 3rd phase trial only recently started? Estimated trial period until?
1 day ago
Thanks @Mikecyc for sharing info.
Haha Tin Kosong MonieM give lectures here ke …no more Shouting Rocket Limit Up ke as in Tsh .. don’t own deleted own posts loh …hahaha
Haha no worries, a few years back , one of Genting Marketing Manager said the Income during the CNY 15 Days can cover 1 Year expenditures, foreseen Shl be improving …
1 day ago
Tks @Peaches L.
for your post for ALL in GB forum.
If everyone here is truly a genuine Gent shareholder, u shud b happy for one another whether it’s TauRx or any other relevant news/information. Why behaving like dog bite dog bone kinda low and childish mentality? Promoting TauRx here benefits Gent shareholders as well. Tis platform shud b a harmonious place for all interested parties to share relevant and useful information for benefit of Gent shareholders primarily. Haiya… lose money quarrel, make money oso quarrel. Family with no peace and harmony disrupts good chi and feng sui energy.
1 day ago
@AngTayKor, your posts are valued by
@Michael_chan2022,
@novel23,
@Peaches L,
@1invest1 and others.
1 day ago
Posted by AngTayKor > 1 month ago | Report Abuse
Firstly, we need to understand with Lucidity's placebo fiasco, full approval is not possible. What we are looking for is Conditional Approval (CA), meaning the regulators agree to let us commercialise HMTM pending results of a new retrial. Usually CA duration is abt 8 yrs (Aduhelm has it for 9 years). The trial design has to be approved by both EMA and FDA otherwise we will be doing 2 trials to satisfy each of them. These days regulators are getting strict with this CA loopholes because some drug companies didnt even do their retrial, some dragged their feet slowly for the trial to max out the CA duration while milking $ selling their drugs, some trials even failed but still selling refuse to pull off from the shelves. Regulators were weak in enforcing such CA approvals but they are getting their acts together now. FDA allows immediate commercialisation upon CA hence subject to a lot of system abuse by pharmas but they are trying to close many loopholes now. I think EMA is currently handling such system abuse better. They will only give the CA licence to commercialise the drug when the agreed retrial has reached full enrollment (all the patients has done their first-time-first-visit at the trial centres). I can talk all day here so better give short answer.
Taurx will submit document to FDA and EMA in March. Thereafter at least 6 months for approval, I suspect more likely 12 months or longer to know the outcome. Taurx have already submitted or submitting soon for some smaller countries for CA. Smaller countries that give fast track probably can get CA faster. Sandy Kingdom, UK, etc. Some some countries' CA may come soon, some later this year.
On the China side, Taurx has cancelled study TRx-237-801 (suppose to be a parallel trial with Lucidity) with the National Medical Products Administration (NMPA). Post Lucidity result, Taurx will be discussing with them on China CA and non-placebo new trial design as the drug can work but the trial did not work under Lucidity's trial design.
---------------------------------
@DestinyL, not so fast yet. Still discussing with China NMPA on HMTM's C.A. and new non-placebo trial design in China. Meanwhile Biogen/Eisai has obtained fast track review for approval in China. But I think their approval wont be smooth eventually as the Chinese regulators are fully aware of Lecanemab's super low drug efficacy (27% slowdown in decline compared to placebo's decline) that comes with high risk of brain swelling/bleeding including numerous death cases.
1 day ago
Eisai didnt fail experiment - TauRx fail experiment/placebo
Aduhelm effectiveness questionable (like TauRx) but approved by FDA - Aduhelm 2022 sales only usd5Mil
** Approval doesnt mean boombastic sales - Dr wont recommend if questionable treatment or got other/better alternative
1 day ago
Aduhelm (FDA approved) only got usd5Mil sales - US known expensive medical cost
TauRx in China will earn much less - cheap healthcare
1 day ago
Ding3 4.66 (+9sen div) highest monthly closing!!
Rebounding nicely from banking panic (panic sell GenT 4 no reason)
Slow steady back to rm5
1 day ago
https://www.sinchew.com.my/?p=4580476
Maybe Anwar bring good news for GenB.. let's see
1 day ago
https://news.cgtn.com/news/2023-03-31/Xi-Jinping-meets-Malaysian-prime-minister-1iCOLNKBqdq/index.html
Xi's meeting with Anwar opens new chapter in China-Malaysia relations
China funds pouring in.. Hou seh liao!
11 hours ago
https://www.channelnewsasia.com/commentary/malaysia-singapore-relations-anwar-unity-government-3387506?cid=internal_sharetool_androidphone_01042023_cna
Anwar's unity government may write a new chapter for Malaysia-Singapore relations
Temasek's fund lai liao..
2023 could be a good year for KLCI. Huat AAAAA!
10 hours ago
Beijing pledges RM170 bil investments in Malaysia: Anwar
This a result of 19 MoUs inked, round-table with Chinese business leaders, says PM
6 hours ago
Post a Comment
Featured Posts
[06 APR] Elliott Wave Analysis - An Accurate & Timely Forecasting Strategy
Looking for REITs with high returns? Check this out!
MQ Trader - Introduction to MQ Trader Affiliate Program
Trending Events
Apps
Top Articles
1
Koon Yew Yin's Blog
2
Stock Pick Contest Year 2023
3
AmInvest Research Reports
4
Koon Yew Yin's Blog
PM Anwar’s visit to boost KL-Beijing strategic ties - Koon Yew Yin
5
Good Articles to Share
6
Good Articles to Share
7
Good Articles to Share
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
morganlee
i just lost money in another counter, no mood to go getting already. contra is the worst idea, gamble is better, at least 50% chance to win
2 days ago